Hans Bishop resigns from Lyell Immunopharma Board and Nominating Committee

Lyell Immunopharma, Inc.

Hans Bishop resigned from the Board and Nominating Committee effective November 22, 2024.
Resignation is not the result of any disagreement or dispute with the Company.
No replacement has been announced; board composition changes accordingly.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Hans Bishop

Director

LYEL · Lyell Immunopharma, Inc.

Effective: 2024-11-22
Filed: November 26, 2024, 6:59 PM ET

On November 22, 2024, Hans Bishop resigned as a member of the Board of Directors (the “Board”) and the Nominating and Corporate Governance Committee of the Board of Lyell Immunopharma, Inc. (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Hans Bishop resigned as Director at Lyell Immunopharma, Inc..

Action: resigned
Role: Director

Exact text from the filing

On November 22, 2024, Hans Bishop resigned as a member of the Board of Directors (the “Board”) and the Nominating and Corporate Governance Committee of the Board of Lyell Immunopharma, Inc. (the “Company”).

View on SEC.gov

Lyell Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-266101

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.